Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
EuroEyes International Eye Clinic (HKSE:01846) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
EuroEyes International Eye Clinic's EV-to-EBIT for today is
EuroEyes International Eye Clinic's current Enterprise Value is HK$548.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. EuroEyes International Eye Clinic's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$111.7 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
EuroEyes International Eye Clinic's EV-to-EBITDA for today is:
EuroEyes International Eye Clinic's current Enterprise Value is HK$548.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. EuroEyes International Eye Clinic's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$133.8 Mil.
EuroEyes International Eye Clinic's current Enterprise Value is HK$548.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. EuroEyes International Eye Clinic's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$796.0 Mil.
EuroEyes International Eye Clinic's current Enterprise Value is HK$548.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. EuroEyes International Eye Clinic's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was HK$193.8 Mil.
EuroEyes International Eye Clinic's current Enterprise Value is HK$548.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. EuroEyes International Eye Clinic's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$148.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic Enterprise Value Related Terms
EuroEyes International Eye Clinic Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic Enterprise Value Chart
HKSE:01846 vs HCA, THC, DVA: Enterprise Value Comparison
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's Enterprise Value distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's Enterprise Value falls into.
EuroEyes International Eye Clinic Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$548.2 Mil mean?
EuroEyes International Eye Clinic (HKSE:01846) has a Enterprise Value of HK$548.2 Mil as of Aug. 05, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on EuroEyes International Eye Clinic and its competitors.
Is EuroEyes International Eye Clinic's Enterprise Value too high?
EuroEyes International Eye Clinic's current Enterprise Value is HK$548.2 Mil. Overall, EuroEyes International Eye Clinic has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's Enterprise Value compare to HCA and THC?
EuroEyes International Eye Clinic's Enterprise Value of HK$548.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on EuroEyes International Eye Clinic and its competitors. EuroEyes International Eye Clinic's current Enterprise Value is HK$548.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.56, compared to a current price of HK$2.50 — trading 55% below its estimated fair value. The current Enterprise Value is HK$548.2 Mil. EuroEyes International Eye Clinic's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current Enterprise Value is HK$548.2 Mil as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.50 is trading 55% below its estimated GF Value™ of HK$5.56.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
Enterprise Value: HK$548.2 Mil
GF Value™: HK$5.56 vs. price of HK$2.50 (55% below fair value)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
83GF Score
Get the complete analysis for HKSE:01846
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
